DHCG and Altruist Partner to Advance Biologics in China
WALNUT CREEK, California, USA & SUZHOU, China | June 3, 2026 Dark Horse Consulting Group (DHCG) and Altruist Biologics...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
WALNUT CREEK, California, USA & SUZHOU, China | June 3, 2026 Dark Horse Consulting Group (DHCG) and Altruist Biologics...
SPOKANE, Wash., May 7, 2026 LiT Biosciences, LLC announced the launch of LiT Protect, a patent-pending botanical dietary supplement...
LOS ANGELES, May 7, 2026 Armata Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted Fast...
SAN JOSE, Calif., USA — April 1, 2026 In a significant advancement in cancer immunotherapy and clinical-stage biotechnology innovation,...
NEW YORK | December 31, 2025 — Intelligent Bio Solutions announced a strategic manufacturing partnership with Syrma Johari MedTech,...
Florham Park, New Jersey | December 22, 2025 — Celularity Inc., a regenerative and cellular medicine company focused on...
Los Angeles, California, November 10, 2025 — Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company pioneering bacteriophage (phage) therapeutics targeting...
San Diego, CA – September 23, 2025 — Gallant, an animal-health biotechnology company specializing in regenerative medicine, announced that...
OKLAHOMA CITY, Sept. 17, 2025 – Wheeler Bio, Inc., a U.S.-based contract development and manufacturing organization (CDMO), announced today...
Andelyn Biosciences, a leading cell and gene therapy CDMO, has partnered with Tern Therapeutics to perform late-stage Process Performance...
